Rénibus Therapeutics
Dr. Jean-Claude Tardif is the Director of the Research Centre at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. Dr. Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal Endowed Research Chair in atherosclerosis. He is the Scientific Director of the Montreal Health Innovations Coordinating Centre (MHICC).
His research covers the molecular and genomic aspects of atherosclerosis and related diseases, involving animal models, mechanistic and observational clinical studies, early clinical studies, and large international randomized trials. He was inducted in the Order of Canada (the highest distinction in the country).
Dr. Tardif graduated from the University of Montreal with his medical degree in 1987 and completed his training in cardiology and research in Montreal and Boston in 1994.
This person is not in the org chart
This person is not in any offices
Rénibus Therapeutics
Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.